Clinicopathological significance of l-type amino acid transporter 1 (lat1) expression in patients with adenoid cystic carcinoma

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 649-656

  Kaira, Kyoichi ^a,b,d   Toyoda, Minoru ^b   Shino, Masato ^b   Sakakura, Koichi ^b   Takahashi, Katsumasa ^b   Tominaga, Hideyuki ^c   Oriuchi, Noboru ^b   Kanai, Yoshikatsu ^e   Oyama, Tetsunari ^b   Chikamatsu, Kazuaki ^b  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d GUNMA UNIVERSITY HOSPITAL   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Adenoid cystic carcinoma; CD98; LAT1; Prognostic factor; Salivary gland

Indexed keywords

AMINO ACID TRANSPORTER; CD34 ANTIGEN; CD98 ANTIGEN; KI 67 ANTIGEN; LAT1 PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROVASCULATURE; PREDICTION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SUBMANDIBULAR GLAND; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD98; CARCINOMA, ADENOID CYSTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 84885180699     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9624-2     Document Type: Article

References (30)

1. Kokemueller H, Eckardt A, Brachvogel P et al (2004) Adenoid cystic carcinoma of the head and neck-a 20 years experience. Int J Oral Maxillofac Surg 33:25-31
2. Perzin KH, Gullane P, Clairmont AC (1978) Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer 42:265-282
3. Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70:43-77
4. McGivan JD, Pastor-Anglada M (1994) Regulatory and molecular aspects of mammalian amino acid transport. Biochem J 299:321-334
5. Kanai Y, Segawa H, Miyamoto K et al (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273:23629-23632
6. Yanagida O, Kanai Y, Chairoungdua A et al (2001) Human L-type amino acid transporter 1 (LAT 1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514:291-302
7. Kobayashi H, Ishii Y, Takayama T (2005) Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol 90:233-238
8. Kaira K, Oriuchi N, Imai H et al (2008) Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer 98:742-748
9. Nakanishi K, Ogata S, Matsuo H et al (2007) Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract. Virchows Arch 451:681-690
10. Nawashiro H, Otani N, Shinomiya N et al (2006) L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 119:484-492
11. Sakata T, Ferdous G, Tsuruta T et al (2009) L-type amino acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol Int 59:7-18
12. Ichinoe M, Mikami T, Yoshida T et al (2011) High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions. Pathol Int 61:281-289
13. Furuya M, Horiguchi J, Nakajima H et al (2012) Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci 103:382-389
14. Kaira K, Oriuchi N, Takahashi T et al (2011) LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer. Am J Transl Res 3:468-478
15. Kaira K, Sunose Y, Arakawa K et al (2012) Prognostic significance of L-type amino acid transporter 1 expression in surgically resected pancreatic cancer. Br J Cancer 107:632-638
16. Chikamatsu K, Shino M, Sakakura K et al (2007) Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in adnoid cystic carcinoma of the head and neck: correlation with clinical outcome. Oral Oncol 43:662-669
17. Arriaga M, Curtin H, Takahashi H et al (1990) Staging proposal auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol 99:714-721
18. Norberg-Spaak L, Dardick I, Ledin T (2000) Adenoid cystic carcinoma: use of cell proliferation, Bcl-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 22:489-497
19. Zhang J, Peng B, Chen X (2005) Expression of nuclear factor B, inducible nitric oxide sunthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11:7334-7343
20. Da Cruz Perez DE, de Abreu AF, Nishimoto IN et al (2006) Prognositc factors in head and neck adenoid cystic carcinoma. Oral Oncol 42:139-146
21. Garden AS, Weber RS, Morrison WH et al (1995) The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Phys 32:619-626
22. Chummun S, Mclean NR, Kelly CG et al (2001) Adenoid cystic carcinoma of the head and neck. Br J Plast Surg 54:476-480
23. Carlinfante G, Lazzaretti M, Ferrari S et al (2005) p53, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. A clinoco-pathologic study of 21 cases with long-term follow-up. Pathol Res Pract 200:791-799
24. Kaira K, Oriuchi N, Imai H et al (2009) Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2hc heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer 66:120-126
25. Jaso J, Mlhotra R (2011) Adenoid cystic carcinoma. Arch Pathol Lab Med 135:511-515
26. Laurie SA, Ho AL, Fury MG et al (2011) Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systemic review. Lancet Oncol 12:815-824
27. Park NS, Kim SG, Kim HK et al (2008) Characterization of amino acid transport system L in HTB-41 human salivary gland epidermoid carcinoma cell. Anticancer Res 28:2649-2656
28. Kim CH, ParK KJ, Park JR et al (2006) The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells. Anticancer Res 26:2943-2948
29. Kim CS, Cho SH, Chun HS et al (2008) BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol Pharm Bull 31:1096-1100
30. Imai H, Kaira K, Oriuchi N et al (2010) Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res 30:4819-4828